Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Tyrosine-protein kinase BTK | ||
Ligand | BDBM368413 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | In Vitro BTK Kinase Assay | ||
IC50 | 505±n/a nM | ||
Citation | Hopkins, BT; Ma, B; Prince, R; Marx, I; Lyssikatos, JP Inhibiting agents for bruton's tyrosine kinase US Patent US10227341 Publication Date 3/12/2019 | ||
More Info.: | Get all data from this article, Assay Method | ||
Tyrosine-protein kinase BTK | |||
Name: | Tyrosine-protein kinase BTK | ||
Synonyms: | AGMX1 | ATK | Agammaglobulinaemia tyrosine kinase | Agammaglobulinemia tyrosine kinase | B cell progenitor kinase | B-cell progenitor kinase | BPK | BTK | BTK_HUMAN | Bruton tyrosine kinase | Tyrosine Kinase BTK | Tyrosine-protein kinase (BTK) | Tyrosine-protein kinase BTK (BTK) | ||
Type: | Enzyme | ||
Mol. Mass.: | 76289.95 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q06187 | ||
Residue: | 659 | ||
Sequence: |
| ||
BDBM368413 | |||
n/a | |||
Name | BDBM368413 | ||
Synonyms: | 3-(tert-butyl)-N-(2-(3- hydroxycyclobutyl)-8-(2- ((1-methyl-1H-pyrazol-4- yl)amino)pyrimidin-4- yl)-2,3,4,5-tetrahydro- 1H-benzo[c]azepin-5-yl)- 1,2,4-oxadiazole-5- carboxamide | US10227341, Compound 68 | ||
Type | Small organic molecule | ||
Emp. Form. | C29H35N9O2S | ||
Mol. Mass. | 573.712 | ||
SMILES | Cn1cc(Nc2nccc(n2)-c2ccc3C(CCN(Cc3c2)C2CC(O)C2)NC(=O)c2nnc(s2)C(C)(C)C)cn1 |(7.53,-4.6,;5.99,-4.6,;5.08,-5.85,;3.62,-5.37,;2.28,-6.14,;.95,-5.37,;-.38,-6.14,;-1.72,-5.37,;-1.72,-3.83,;-.38,-3.06,;.95,-3.83,;-.38,-1.52,;.95,-.75,;.95,.79,;-.49,1.53,;-.49,3.17,;-1.69,4.13,;-3.19,3.79,;-3.86,2.4,;-3.19,1.02,;-1.69,.67,;-1.72,-.75,;-5.35,2.8,;-6.12,4.14,;-7.45,3.37,;-8.94,3.76,;-6.68,2.03,;.83,3.98,;2.18,3.24,;2.21,1.7,;3.49,4.04,;3.49,5.58,;4.96,6.06,;5.86,4.81,;4.96,3.57,;7.4,4.81,;8.17,6.14,;8.17,3.48,;8.94,4.81,;3.62,-3.83,;5.08,-3.36,)| | ||
Structure |